Stock Scorecard
Stock Summary for Zimmer Biomet Holdings Inc (ZBH) - $119.75 as of 4/26/2024 3:59:11 PM EST
Total Score
11 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ZBH
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZBH
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZBH
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for ZBH
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for ZBH
Financial Details for ZBH
Company Overview |
|
---|---|
Ticker | ZBH |
Company Name | Zimmer Biomet Holdings Inc |
Country | USA |
Description | Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. |
Sector Name | LIFE SCIENCES |
Industry Name | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/2/2024 |
Stock Price History |
|
Last Day Price | 119.75 |
Last Day Price Updated | 4/26/2024 3:59:11 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 1,182,377 |
52-Week High | 148.10 |
52-Week Low | 101.61 |
Last Price to 52 Week Low | 17.85% |
Valuation Measures |
|
Trailing PE | 24.64 |
Industry PE | 60.69 |
Sector PE | 56.64 |
5-Year Average PE | 15.32 |
Free Cash Flow Ratio | 59.28 |
Industry Free Cash Flow Ratio | 37.87 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 1.61 |
Total Cash Per Share | 2.02 |
Book Value Per Share Most Recent Quarter | 60.70 |
Price to Book Ratio | 2.05 |
Industry Price to Book Ratio | 6.35 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 3.46 |
Industry Price to Sales Ratio Twelve Trailing Months | 7.00 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 205,461,000 |
Market Capitalization | 24,603,954,750 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 3/27/2024 |
Last Dividend Amount | 0.24 |
Current Dividend Amount | 0.24 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.96 |
Trailing Annual Dividend Yield | 0.80% |
Forward Annual Dividend Rate | 0.96 |
Forward Annual Dividend Yield | 0.80% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 0.77% |
5-Year Average Dividend Yield | 0.72% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 2.65% |
Dividend Payout Ratio | 19.63% |
Income Statement |
|
Quarterly Earnings Growth YOY | -16.30% |
Annual Earnings Growth | 342.52% |
Reported EPS 12 Trailing Months | 4.88 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 7.56 |
Net Income Twelve Trailing Months | 1,024,000,000 |
Net Income Past Year | 1,024,000,000 |
Net Income Prior Year | 231,400,000 |
Quarterly Revenue Growth YOY | 6.30% |
5-Year Revenue Growth | -1.16% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 415,800,000 |
Total Cash Past Year | 415,800,000 |
Total Cash Prior Year | 375,700,000 |
Net Cash Position Most Recent Quarter | -6,086,300,000 |
Net Cash Position Past Year | -6,086,300,000 |
Long Term Debt Past Year | 6,502,100,000 |
Long Term Debt Prior Year | 5,453,300,000 |
Total Debt Most Recent Quarter | 6,502,100,000 |
Equity to Debt Ratio Past Year | 0.66 |
Equity to Debt Ratio Most Recent Quarter | 0.66 |
Total Stockholder Equity Past Year | 12,480,500,000 |
Total Stockholder Equity Prior Year | 12,020,300,000 |
Total Stockholder Equity Most Recent Quarter | 12,480,500,000 |
Options |
|
Put/Call Ratio | 0.12 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -1.71 |
MACD Signal | -0.99 |
20-Day Bollinger Lower Band | 116.78 |
20-Day Bollinger Middle Band | 123.72 |
20-Day Bollinger Upper Band | 130.65 |
Beta | 1.02 |
RSI | 36.46 |
50-Day SMA | 123.47 |
200-Day SMA | 128.39 |
System |
|
Modified | 4/27/2024 3:20:50 PM EST |